MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

First Tracks Biotherapeutics, Inc. (TRAX)

First Tracks Biotherapeutics, Inc. (TRAX)

|||

Balance Sheets Overview

Current Ratio
874.01%
Quick Ratio
874.01%
Cash Ratio
750.39%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Short-term investments
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Net parent investment
    • Accounts payable
    • Accumulated other comprehensive ...
    • Others

Balance Sheets
2026-03-31
Cash and cash equivalents
248,469
Short-term investments
37,986
Prepaid expenses and other current assets
2,947
Total current assets
289,402
Property and equipment, net
1,174
Operating lease right-of-use assets
0
Other long-term assets
0
Total assets
290,576
Accounts payable
7,496
Accrued expenses
25,616
Current portion of operating lease liability
0
Total current liabilities
33,112
Operating lease liability, net of current portion
0
Net parent investment
257,610
Accumulated other comprehensive loss
-146
Equity, attributable to parent, total
257,464
Total liabilities and equity
290,576
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$248,469K Short-term investments$37,986K Prepaid expenses andother current assets$2,947K Total current assets$289,402K Property and equipment,net$1,174K Total assets$290,576K Total liabilities andequity$290,576K Equity, attributable toparent, total$257,464K Total currentliabilities$33,112K Accumulated othercomprehensive loss-$146K Net parentinvestment$257,610K Accrued expenses$25,616K Accounts payable$7,496K